Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients First ACCCESS patient expected to be implanted in Q4 2022 Mont-Saint-Guibert, Belgium – July 11, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company […]

Read more

OKX becomes Training Kit Partner of Premier League Champions Manchester City

The new agreement will see OKX become Official Training Kit partner for the 2022/23 season. To celebrate the announcement, OKX has commissioned renowned street artist Akse P19 and Global Street Art Agency to create artworks featuring Manchester City players Haaland, Grealish, Cancelo and Stones, across four locations in Manchester. Last week, OKX were also announced […]

Read more

ROSEN, A TOP RANKED LAW FIRM, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TDOC

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the “Class Period”), of the important August 5, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read more

OKTA DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Okta, Inc. Investors with Losses to Secure Counsel Before Important July 19 Deadline in Securities Class Action – OKTA

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Okta, Inc. (NASDAQ: OKTA) between March 5, 2021 and March 22, 2022, both dates inclusive (the “Class Period”), of the important July 19, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read more

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October 28, 2021 and May 2, 2022, both dates inclusive (the “Class Period”), of the important than July 25, 2022 lead plaintiff deadline. SO WHAT: […]

Read more

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages IonQ, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – IONQ

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IonQ, Inc. (NYSE: IONQ) between March 30, 2021 and May 2, 2022, both dates inclusive (the “Class Period”), of the important August 1, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read more